Early dynamics of hepatitis C virus in the circulation of chimpanzees with experimental infection

Intervirology

Volumn 48, Issue 2-3, 2005, Pages 120-123

  Tanaka, Junko ^a   Katayama, Keiko ^a   Kumagai, Junko ^a   Komiya, Yutaka ^a   Yugi, Hisao ^b   Kishimoto, Shinya ^c   Mizui, Masaaki ^d   Tomoguri, Tetsushi ^e   Miyakawa, Yuzo ^f   Yoshizawa, Hiroshi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Tokyo Red Cross Blood Center   (Japan)

^c Japanese Red Cross Saitama Blood Center   (Japan)

^d JAPANESE RED CROSS SOCIETY   (Japan)

^e SANWA KAGAKU KENKYUSHO CO LTD   (Japan)

^f Miyakawa Memorial Research Foundation   (Japan)

Author keywords

Chimpanzees; Chronic hepatitis; Hepatitis C virus; Nucleic acid amplification testing; Transfusion

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; VIROGENESIS; VIRUS DETECTION; ANIMAL; BLOOD; DISEASE MODEL; KINETICS; PAN TROGLODYTES; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIROLOGY;

HEPATITIS C VIRUS; PAN (APE);

VIRUS RNA;

ANIMALS; DISEASE MODELS, ANIMAL; HEPACIVIRUS; HEPATITIS C; KINETICS; PAN TROGLODYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIREMIA;

EID: 21544470992     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081738     Document Type: Article

References (10)

1. Tobler LH, Stramer SL, Lee SR, Masecar BL, Peterson JE, Davis EA, Andrews WE, Brodsky JP, Kleinman SH, Phelps BH, Busch MP: Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening. Transfusion 2003;43:1452-1459.
2. Beach MJ, Meeks EL, Mimms LT, Vallari D, DuCharme L, Spelbring J, Taskar S, Schleicher JB, Krawczynski K, Bradley DW: Temporal relationships of hepatitis C virus RNA and antibody responses following experimental infection of chimpanzees. J Med Virol 1992;36:226-237.
3. Busch MP, Kleinman SH, Jackson B, Stramer SL, Hewlett I, Preston S: Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion 2000;40:143-159.
4. Roth WK, Weber M, Seifried E: Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet 1999;353:359-363.
5. Weusten JJ, van Drimmelen HA, Lelie PN: Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion 2002;42:537-548.
6. Schuttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S: Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet 2000;355:41-42.
7. Busch MP, Giachetti C, Gallarda J, Mimms LT, Peddada L, Charles H, Raia S, Fiebig EW, Wright D: Dynamics of HCV viremia during early HCV infection: Implication for minipool vs. individual donation nucleic acid amplification testing (abstract). Transfusion 2000;40:S25.
8. Katayama K, Kumagai J, Komiya Y, Mizui M, Yugi H, Kishimoto S, Yamanaka R, Tamatsukuri S, Tomoguri T, Miyakawa Y, Yoshizawa H: Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission. Intervirology 2004;47:57-64.
9. Shimizu YK, Weiner AJ, Rosenblatt J, Wong DC, Shapiro M, Popkin T, Houghton M, Alter HJ, Purcell RH: Early events in hepatitis C virus infection of chimpanzees. Proc Natl Acad Sci USA 1990;87:6441-6444.
10. Glynn SA, Kleinman SH, Wright DJ, Busch MP: International application of the incidence rate/window period model. Transfusion 2002;42:966-972.